s6y

3 CytomX Therapeutics, Inc.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0000899243-15-006443

Documents

  1. FORM 3 SUBMISSION 3
  2. EX-24 DOCUMENT EX-24
  3. EX-99 DOCUMENT EX-99

On sec.gov